Cyfystyron:

Fondaparin SodiuM; Methyl O-2-Deoxy-6-O-sulfo-2-(sulfoaMino)-α-D-glucopyranosyl-(14)-O-β-
D-glucopyranuronosyl-(14)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoaMino)-α-D-glucopyranosyl-(14)-O-2-O-sulfo-α- L-idopyranuronosyl-(14)-2-deoxy-2-(sulfoaMino)-α-D-glucopyranoside 6-(Hydrogen Sylffad) DecasodiuM Halen; Adnabod Fondaparinux SodiuM; Fondaparinux sodiwm, >=98%; Methyl O-2-Deoxy -6-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(14)-O-β- D-glucopyranuronosyl-(14)-O-2-deoxy-3,6-di-O-sulfo -2-(sulfoamino)-α-D-glucopyranosyl-(14)-O-2-O-sulfo-α-L-idopyranuronosyl-(14)-2-deoxy-2-(sulfoamino)-α-D-glucopyra ; Fondaparinux sodiwm N-4; decasodium (2R, 3S, 4S, 5R, 6R) -3-[(2R,3R,4R,6R)-5-[(2R,3R,4S,5S,6S)-6- carboxylato-5-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-(sulfonatooxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-oxan- 2-yl] ocsi-3-(sulfonatoamino)-4-sulfonatooxy-6-(sulfonatooxymethyl)oxan-2-yl]oxy-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4- hydroxy-6-methoxy-5- (sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-5-sulfonatooxy-oxane-2-carboxylate; Fondaparinux sodiwm

Gwenau Canonaidd:COC1C(C(C(C(O))COS(=O)(=O)[O-]))OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O)3 )COS(=O)(=O)[O-])OC4C(C(C(C(O4)C(=O)O))OC5C(C(C(C(C(O))COS(=O)(=O) )[O-])O)O)NS(=O)(=O)(O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O) )[O-])O)OS(=O)(=O)(O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+]. [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]

Cod HS:3822000002

Storio:-70°C